CCND2 and breast carcinoma: Adjusted for sex, race, age, tumor type, and stage, the multivariate Cox proportional hazard model analysis showed a significant correlation of CCND2 expression with the five-year overall survival in lung cancer and 10-year overall survival in breast cancer (Table 2, p = 0.021 and 0.001, respectively).